OpenNashPodcasts

Topic

Harvard Medical School

7 facts from 6 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.

2022

Sinclair said the eye age-reversal therapy would be tested in monkeys first, with a first human patient expected in 2022 or early 2023 to try to restore vision.

“we're going to be testing the treatment on, um, monkeys, uh, for just for safety reasons, uh, and then the first patient should be done sometime in 2022, early 2023, and we're gonna try to recover blindness.”

David Sinclair · The Biology of Slowing & Reversing Aging | Dr. David Sinclair, 1:38:42

Undated

Before Mayo, Halamka spent 22 years in Boston, serving as chief information officer of Harvard Medical School and Beth Israel Deaconess and working on regional and national policy.

“Both, you know, as CIO of Harvard Medical School and Beth Israel Deaconess, and then working in our regional area and nationally on policy matters.”

John Halamka · Episode #03. Big Data, AI and ML Technologies, The Future of Healthcare Transformation with John Halamka, president of the Mayo Clinic Platform, 0:01:50

Episodes